Applications Of Sustained Release Dosage Form For Neuro Disorder: An Overview

Abstract

This article offers a comprehensive overview of several facets pertaining to sustained/controlled drug release formulations used in the treatment of neurodegenerative diseases (NDs). Considering the brain's crucial role in the regulation of diverse physiological processes, it can be inferred that neurodegenerative disorders exert a wide-ranging influence on human functionality. These conditions detrimentally affect fundamental capacities such as speech, movement, stability, and balance, as well as more intricate tasks encompassing bladder and bowel functions, along with cognitive abilities. The current neurodegenerative disorders (NDs) consist of a variety of illnesses, including Alzheimer's disease, Parkinson's disease, prion disease, Amyotrophic lateral sclerosis (ALS), motor neuron disease, Huntington's disease, spinal muscular atrophy, and spinocerebellar ataxia, which are often seen. There is a limited number of SRDDS/CRDDS that have been created for various medications aimed at treating neurological disorders (NDs). Consequently, our research efforts are focused on developing a sustained release tablet formulation intended for the treatment of neurodegenerative disorders (NDs).